
Dolo-650 being unethically prescribed to patients during the pandemic is just the latest example of drug companies’ malpractices, senior advocate Sanjay Parikh told publication Down To Earth. Different strategies are used to promote drugs to categories of doctors — core doctors and secondary doctors in which core doctors are those who give business to the company. An additional category includes specialists, doctors with a good reputation, opinion leaders.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4vYFofQ
via
IFTTT
0 comments:
Post a Comment